Diabetes in the Western Pacific Region-Past, Present and Future

Diabetes Research and Clinical Practice

Volumn 103, Issue 2, 2014, Pages 244-255

  Chan, Juliana C N ^a   Cho, Nam H ^b   Tajima, Naoko ^c   Shaw, Jonathan ^d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Ajou University School of Medicine   (South Korea)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Diabetes; Epidemiology; Management; Western Pacific Region

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CULTURAL ANTHROPOLOGY; DIABETES CONTROL; DIABETES MELLITUS; DIET THERAPY; ETHNIC DIFFERENCE; FAMILY HISTORY; GENETIC DIFFERENCE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH PROMOTION; HEREDITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LIFESTYLE MODIFICATION; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PACIFIC ISLANDS; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SOCIAL CLASS; SOCIAL STATUS; SOCIAL STRESS; ADOLESCENT; ADULT; AGED; CHILD; CHINA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; ETHNIC GROUP; FEMALE; GLUCOSE INTOLERANCE; LIFESTYLE; MIDDLE AGED; PEDIATRIC OBESITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHINA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; LIFE STYLE; MIDDLE AGED; PACIFIC ISLANDS; PEDIATRIC OBESITY; PREVALENCE; YOUNG ADULT;

EID: 84895798241     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.11.012     Document Type: Article

References (130)

1. Chan J.C., Malik V., Jia W., Kadowaki T., Yajnik C.S., Yoon K.H., Hu F.B. Diabetes in Asia Epidemiology, risk factors, and pathophysiology. JAMA 2009, 301:2129-2140.
2. Tajiman N., La Porte R.E., Hibi I., Kitagawa T., Fujita H., Drash A.L. A comparison of the epidemiology of youth-onset insulin-dependent diabetes mellitus between Japan and the United Sates (Allegheny County, Pennsylvania). Diabetes Care 1985, 8(Suppl. 1):17-23.
3. Morrish N.J., Wang S., Stevens L.K., Fuller J.H., Keen H. Mortality and causes of death in the WHO Multinational Survey of Vascular Diseases in Diabetes. Diabetologia 2001, 44:S14-S21.
4. Yoon K.H., Lee J.H., Kim J.W., Cho J.H., Choi Y.H., Ko S.H., et al. Epidemic of obesity and type 2 diabetes in Asia. Lancet 2006, 368:1681-1688.
5. Ramachandran A., Ma R.C.W., Snehalatha C. Diabetes in Asia. Lancet 2010, 375:408-418.
6. International Diabetes Atlas 2013, International Diabetes Federation (Ed.).
7. Guariguata L., Beagley J., Linnenkamp U., Hambleton I., Shaw J., Cho N.H., et al. Global estimates of prevalence of diabetes in adults for 2013 and projections to 2035 from the IDF diabetes Atlas. Diabetes Res Clin Pract 2013, [in press].
8. Stevens G.A., Singh G.M., Lu Y., Danaei G., Lin J.K., Finucane M.M., et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. National, regional, and global trends in adult overweight and obesity prevalences. Population health metrics 2012, 10:22. 10.1186/1478-7954-10-22.
9. DeCODA Study Group Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the NCEP definition. Diabetes Res Clin Pract 2007, 76:57-67.
10. Khambalia A., Phongsavan P., Smith B.J., Keke K., Dan L., Fitzhardinge A., Bauman A.E. Prevalence and risk factors of diabetes and impaired fasting glucose in nauru. BMC Public Health 2011, 11:719. 10.1186/1471-2458-11-719.
11. Dancause K.N., Dehuff C., Soloway L.E., Vilar M., Chan C., Wilson M., et al. Behavioral changes associated with economic development in the South Pacific: Health transition in Vanuatu. American Journal of Human Biology 2011, 23:366-376.
12. Xu Y., Wang L., He J., Bi Y., Li M., Wang T., et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013, 310:948-959. On behalf of the 2010 China Non-communicable Disease Surveillance Group.
13. Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101.
14. Jia W., Xiang K., Chen L., Lu J., Wu Y. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev 2002, 3:157-165.
15. Laakso M., Pyorala K. Age of onset and type of diabetes. Diabetes Care 1985, 8:114-117.
16. Kong A.P.S., Chan J.C.N. Other disorders with type 1 phenotype. Textbook of Diabetes 2010, 152-159. Wiley-Blackwell, a John Wiley & Son Ltd. publication, Chichester, UK. R. Holt, B. Goldstein, A. Flyvbjerg, C.S. Cockram (Eds.).
17. Haynes A., Bower C., Bulsara M.K., Jones T.W., Davis E.A. Continued increase in the incidence of childhood Type 1 diabetes in a population-based Australian sample (1985-2002). Diabetologia 2004, 47:866-870.
18. Tajima N., Morimoto A. Epidemiology of childhood diabetes mellitus in Japan. Pediatr Endocrinol Rev 2012, 10(Suppl. 1):44-50.
19. Morimoto A., Onda Y., Nishimura R., Sano H., Utsunomiya K., Tajima N. Diabetes Epidemiology Research International Mortality Study Group. Cause-specific mortality trends in a nationwide population-based cohort of childhood-onset type 1 diabetes in Japan during 35 years of follow-up: The Deri Mortality Study. Diabetologia 2013, 56:2171-2175.
20. Kobayashi T., Tamemoto K., Nakanishi K., Kato N., Okubo M., Kajio H., et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 1993, 16:780-788.
21. Zhou Z., Xiang Y., Ji L., Jia W., Ning G., Huang G., et al. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China Study Group): A nationwide, multicenter, clinic-based cross-sectional study. Diabetes 2013, 62:543-550.
22. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
23. Ma R.C., Chan J.C., Diabetes: incidence of childhood type 1 diabetes: a worrying trend. Nat Rev Endocrinol 2009, 5:529-530.
24. Alberti G., Zimmet P., Shaw J., Bloomgarden Z., Kaufman F., Silink M., et al. Type 2 diabetes in the young: The evolving epidemic: The International Diabetes Federation Consensus Workshop. Diabetes Care 2004, 27:1798-1811. Consensus Workshop Group.
25. Seshasai S.R., Kaptoge S., Thompson A., Di Angelantonio E., Gao P., SarwarF N., et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011, 364:829-841.
26. Luk A.O.Y., Lau E., So W.Y., Ma R.C.W., Kong A.P.S., Ozaki R., Chow F.C.C, et al. Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes mellitus. Diabetes Care 2014, 37:1-9. 10.2337/dc13-1336.
27. Zhao W., Zhai Y., Hu J., Wang J., Yang Z., Kong L., et al. Economic burden of obesity-related chronic diseases in Mainland China. Obesity reviews 2008, 9(Suppl. 1):62-67.
28. Lee C.M., Colagiuri R., Magliano D.J., Cameron A.J., Shaw J., Zimmet P., et al. The cost of diabetes in adults in Australia. Diabetes Res Clin Pract 2013, 99:385-390.
29. Chang T.J., Jiang Y.D., Chang C.H., Chung C.H., Yu N.C., Chuang L.M. Accountability, utilization and providers for diabetes management in Taiwan, 2000-2009: an analysis of the National Health Insurance database. J Formos Med Assoc 2012, 111:605-616.
30. Wang W., Fu C., Zhuo H., Luo J., Xu B. Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban China. BMC Health Serv Res 2010, 10:244.
31. Goldhaber-Fiebert J.D., Li H., Ratanawijitrasin S., Vidyasagar S., Wang X.Y., Aljunid S., et al. Inpatient treatment of diabetic patients in Asia: Evidence from India, China, Thailand and Malaysia. Diabetic Medicine 2010, 27:101-108.
32. Li R., Zhang P., Barker L.E., Chowdhury F.M., Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care 2011, 33:1872-1894.
33. Li G., Zhang P., Wang J., Gregg E.W., Yang W., Gong Q., et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: A 20-year follow-up study. Lancet 2008, 371:1783-1789.
34. Yang W., Lin L., Qi J., Yu Z., Pei H., He G., et al. The preventive effect of acarbose and metformin on the progression to diabetes mellitus in the IGT population: A 3-year multicentre prospective study. Chinese Journal of Endocrinology and Metabolism 2001, 17:131-136.
35. Kawamori R., Tajima N., Iwamoto Y., Kashiwagi A., Shimamoto K., Kaku K. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. Lancet 2009, 373:1607-1614.
36. Luk A.O., Yang X., Ma R.C., Ng V.W., Yu L.W., Lau W.W., et al. Association of statin use and development of renal dysfunction in type 2 diabetes - the Hong Kong Diabetes Registry. Diabetes Res Clin Pract 2010, 88:227-233.
37. Ting R.Z., Yang X., Yu L.W., Luk A.O., Kong A.P., Tong P.C., et al. Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: A prospective cohort study. Cardiovascular diabetology 2011, 9(77). 10.1186/475-2840-9-77.
38. So W.Y., Chan N., Tong P.C.Y., Chow C.C., Chan W.B., Ng M.C.Y., et al. Effect of RAAS inhibition on survival and renal outcomes in 3737 Chinese type 2 diabetic patients. Hypertension 2004, 44:294-299.
39. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 1995, 28:103-117.
40. Leung W.Y.S., So W.Y., Tong P.C.Y., Chan N.N., Chan J.C.N. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy. Am J Med 2005, 118(1414):e421-e427.
41. Chan J.C., So W.Y., Yeung C.Y., Ko G.T., Lau I.T., Tsang M.W., et al. Effects of structured versus usual care on renal endpoint in type 2 diabetes: The SURE study: A randomized multicenter translational study. Diabetes Care 2009, 32:977-982.
42. So W.Y., Yang X., Ma R.C., Kong A.P., Lam C.W., Ho C.S., et al. Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes - the Hong Kong Diabetes Registry. Diabetes Metabolism Research and Reviews 2008, 24:238-246.
43. Li H.Y., Jiang Y.D., Chang C.H., Chung C.H., Lin B.J., Chuang L.M. Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000-2009. J Formos Med Assoc 2012, 111:645-650.
44. Win Tin S.T., Gadabu E., Iro G., Tasserei J., Colagiuri R. Diabetes related amputations in Pacific Islands countries: a root cause analysis of precipitating events. Diabetes Res Clin Pract 2013, 100:230-234.
45. Wu A.Y., Kong N.C., de Leon F.A., Pan C.Y., Tai T.Y., Yeung V.T., et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: The microalbuminuria prevalence (MAP) study. Diabetologia 2005, 48:1674-1675.
46. Luk A.O., So W.Y., Ma R.C., Kong A.P., Ozaki R., Ng V.S., et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: A 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 2008, 31:2357-2361.
47. Cheng A.Y., Kong A.P., Wong V.W., So W.Y., Chan H.L., Ho C.S., et al. Chronic Hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients. Diabetologia 2006, 49:1777-1784.
48. Wen C.P., Cheng T.Y., Tsai M.K., Chang Y.C., Chan H.T., Tsai S.P., et al. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008, 371:2173-2182.
49. Williams E.D., Magliano D.J., Tapp R.J., Oldenburg B.F., Shaw J.E. Psychosocial stress predicts abnormal glucose metabolism: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Ann Behav Med 2013, 46:62-72.
50. Kaur G., Tee G.H., Ariaratnam S., Krishnapillai A.S., China K. Depression, anxiety and stress symptoms among diabetics in Malaysia: a cross sectional study in an urban primary care setting. BMC Fam Pract 2013, 14:69.
51. Zhang Y., Ting R., Lam M., Lam J., Nan H., Yeung R., et al. Measuring depressive symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetes. Journal of affective disorders 2013, 151:660-666.
52. Ting R.Z., Lau E.S., Ozaki R., Lau W.W., Kong A.P., Luk A.O., et al. High risk for cardiovascular disease in Chinese type 2 diabetic patients with major depression--a 7-year prospective analysis of the Hong Kong Diabetes Registry. Journal of Affective Disorders 2013, 149:129-135.
53. Ting R.Z., Nan H., Yu M.W., Kong A.P., Ma R.C., Wong R.Y., et al. Diabetes-related distress and physical and psychological health in Chinese type 2 diabetic patients. Diabetes Care 2011, 34:1094-1096.
54. Cong J.Y., Zhao Y., Xu Q.Y., Zhong C.D., Xing Q.L. Health-related quality of life among Tianjin Chinese patients with type 2 diabetes: a cross-sectional survey. Nurs Health Sci 2012, 14:528-534.
55. Sheu W.H., Ji L.N., Nitiyanant W., Baik S.H., Yin D., Mavros P., Chan S.P., et al. Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region. Diabetes Res Clin Pract 2012, 96:141-148.
56. Nguyen Q.N., Pham S.T., Do L.D., Nguyen V.L., Wall S., Weinehall L., et al. Cardiovascular disease risk factor patterns and their implications for intervention strategies in Vietnam. International Journal of Hypertension 2012, 2012:560397. 10.1155/2012/560397.
57. Otgontuya D., Oum S., Palam E., Rani M., Buckley B.S. Individual-based primary prevention of cardiovascular disease in Cambodia and Mongolia: early identification and management of hypertension and diabetes mellitus. BMC Public Health 2012, 12:254.
58. Deurenberg-Yap M., Schmidt G., van Staveren W.A., Deurenberg P. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes 2000, 24:1011-1017.
59. King G.L., McNeely M.J., Thorpe L.E., Mau M.L., Ko J., Liu L.L., et al. Understanding and addressing unique needs of diabetes in Asian Americans, native Hawaiians, and Pacific Islanders. Diabetes Care 2012, 35:1181-1188.
60. Dickinson S., Colagiuri S., Faramus E., Petocz P., Brand-Miller J.C. Postprandial hyperglycemia and insulin sensitivity differ among lean young adults of different ethnicities. J Nutr 2002, 132:2574-2579.
61. Nishi Y., Fukushima M., Suzuki H., Mitsui R., Ueda N., Taniguchi A., et al. Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia. Diabetes Res Clin Pract 2005, 70:46-52.
62. Kuroe A., Fukushima M., Usami M., Ikeda M., Nakai Y., Taniguchi A., et al. Impaired beta-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance. Diabetes Res Clin Pract 2003, 59:71-77.
63. Suraamornkul S., Kwancharoen R., Ovartlarnporn M., Rawdaree P., Bajaj M. Insulin clamp-derived measurements of insulin sensitivity and insulin secretion in lean and obese Asian type 2 diabetic patients. Metab Syndr Relat Disord 2010, 8:113-118.
64. Kong A.P.S., Xu G., Brown N., So W.Y., Ma R.C., Chan J.C.N. Diabetes and its comorbidities - where East meets West. Nat Rev Endocrinol 2013, 10.1038/nrendo.2013.102.
65. Ma R.C., Chan J.C.N. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 2013, 1281:64-91.
66. Ng M.C., Park K.S., Oh B., Tam C.H., Cho Y.M., Shin H.D., et al. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 2008, 57:2226-2233.
67. Cho Y.S., Chen C.H., Hu C., Long J., Hee Ong R.T., Sim X., et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in East Asians. Nature Genetics 2011, 44:67-72.
68. Yamauchi T., Hara K., Maeda S., Yasuda K., Takahashi A., Horikoshi M., et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nature Genetics 2010, 42:864-868.
69. Ma R.C., Hu C., Tam C.H., Zhang R., Kwan P., Leung T.F., et al. Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia 2013, 56:1291-1305.
70. Li J.K.Y., Ng M.C.Y., So W.Y., Chiu C., Ozaki R., Tong P.C.Y., et al. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metabolism Research and Reviews 2006, 22:46-52.
71. Tam C.H., Lam V.K., So W.Y., Ma R.C., Chan J.C., Ng M.C. Genome-wide linkage scan for factors of metabolic syndrome in a Chinese population. BMC Genet 2010, 11:14. 10.1186/1471-2156-11-14.
72. Xiang K., Wang Y., Zheng T., Jia W., Li J., Chen L., et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes 2004, 53:228-234.
73. Ng M.C., So W.Y., Cox N.J., Lam V.K.L., Cockram C.S., Bell G.I., et al. Genome wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-25. Diabetes 2004, 53:2676-2683.
74. Diamond J.M. Diabetes running wild. Nature 1992, 357:362-363.
75. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008, 359:61-73.
76. Kim C., Newton K.M., Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25:1862-1868.
77. Jang H.C., Min H.K., Lee H.K., Cho N.H., Metzger B.E. Short stature in Korean women: a contribution to the multifactorial predisposition to gestational diabetes mellitus. Diabetologia 1998, 41:778-783.
78. Cheung N.W., Byth K. Population health significance of gestational diabetes. Diabetes Care 2003, 26:2005-2009.
79. Tam W.H., Ma R.C., Yang X., Ko G.T., Tong P.C., Cockram C.S., et al. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero. Pediatrics 2008, 122:1229-1234.
80. Ma R.C., Chan J.C., Tam W.H., Hanson M.A., Gluckman P.D. Gestational diabetes, maternal obesity, and the NCD Burden. Clin Obstet Gynecol 2013, 56:633-641.
81. Djousse L., Driver J.A., Gaziano J.M., Buring J.E., Lee I.M. Association between modifiable lifestyle factors and residual lifetime risk of diabetes. Nutr Metab Cardiovasc Dis 2013, 23:17-22.
82. Willi C., Bodenmann P., Ghali W.A., Faris P.D., Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007, 298:2654-2664.
83. Cho N.H., Chan J.C., Jang H.C., Lim S., Kim H.L., Choi S.H. Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study. Clin Endocrinol (Oxf) 2009, 71:679-685.
84. Hansen A.L., Wijndaele K., Owen N., Magliano D.J., Thorp A.A., Shaw J.E., et al. Adverse associations of increases in television viewing time with 5-year changes in glucose homeostasis markers: The AusDiab study. Diabetic Medicine 2012, 29:918-925.
85. Yu R., Woo J., Chan R., Sham A., Ho S., Tso A., et al. Relationship between dietary intake and the development of type 2 diabetes in a Chinese population: The Hong Kong Dietary Survey. Public Health Nutrition 2011, 14:1133-1141.
86. Malik V.S., Willett W.C., Hu F.B. Sugar-sweetened beverages and BMI in children and adolescents: reanalyses of a meta-analysis. Am J Clin Nutr 2009, 89:438-439. author reply 9-40.
87. Harding J.L., Backholer K., Williams E.D., Peeters A., Cameron A.J., Hare M.J., et al. Psychosocial stress is positively associated with body mass index gain over 5 years: Evidence from the longitudinal AusDiab study. Obesity 2013, 10.1002/oby.20423.
88. Cappuccio F.P., D'Elia L., Strazzullo P., Miller M.A. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010, 33:414-420.
89. International Diabetes Federation Diabetes Atlas 2006, 3rd ed.
90. Ko G.T.C., Chan J.C.N., Cockram C.S. A low socioeconomic class is associated with diabetes and metabolic syndrome in Hong Kong Chinese. Eur J Epidemiol 2001, 17:289-295.
91. Ko G.T., Chan J.C., Chan A.W., Wong P.T., Hui S.S., Tong S.D., et al. Low levels of awareness of suboptimal health conditions in a high-risk working population: The "Better Health For Better Hong Kong" health promotion campaign. Int J Behav Med 2007, 14:63-69.
92. Wong M.C., Leung M.C., Tsang C.S., Lo S.V., Griffiths S.M. The rising tide of diabetes mellitus in a Chinese population: a population-based household survey on 121,895 persons. Int J Public health 2013, 58:269-276.
93. Lao T.T., Chan B.C., Leung W.C., Ho L.F., Tse K.Y. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol 2007, 47:46-50.
94. Cani P.D., Delzenne N.M., Amar J., Burcelin R. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol 2008, 56:305-309.
95. Lim S., Cho Y.M., Park K.S., Lee H.K. Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome. Ann NY Acad Sci 2010, 1201:166-176.
96. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27:813-823.
97. Fisher E.B., Chan J.C.N., Nan H., Sartorius N., Oldenburg B. Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge. J Affect Disord 2012, 142(Suppl.):S56-S66.
98. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589.
99. Gaede P., Valentine W.J., Palmer A.J., Tucker D.M., Lammert M., Parving H.H., et al. Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: Results and projections from the Steno-2 study. Diabetes Care 2008, 31:1510-1515.
100. Kong A.P., Yang X., Ko G.T., So W.Y., Chan W.B., Ma R.C., et al. Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes. Diabetes Care 2007, 30:953-959.
101. Chan J.C.N., Gagliardino J.J., Baik S.H., Chantelot J.M., Ferreirae S.R.G., Hancuf N., et al. Multi-faceted determinants for achieving glycaemic control: The international Ddiabetes Management Practice Study (IDMPS). Diabetes Care 2009, 32:227-233. on behalf of the IDMPS investigators.
102. Chuang L.M., Soegondo S., Soewondo P., Young-SeolF K., Mohamed M., Dalisay E., et al. Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia. Diabetes Res Clin Pract 2006, 71:146-155.
103. David A.M., Rubio J.M., Luces P.S., Zabala R.V., Roberto J.P. Getting the patients' perspective: a survey of diabetes services on Guam. Hawaii Med J 2010, 69:45-49.
104. Popkin B.M. Is the obesity epidemic a national security issue around the globe?. Curr Opin Endocrinol Diabetes Obes 2011, 18:328-331.
105. Mackay J., Ritthiphakdee B., Reddy K.S. Tobacco control in Asia. Lancet 2013, 381:1581-1587.
106. Inzucchi S.E., Sherwin R.S. The prevention of type 2 diabetes mellitus. Endocrinol Metab Clin North Am 2005, 34:199-219. viii.
107. Brown N., Critchley J., Bogowicz P., Mayige M., Unwin N. Risk scores based on self-reported or available clinical data to detect undiagnosed Type 2 Diabetes: a systematic review. Diabetes Res Clin Pract 2012, 98:369-385.
108. CDC Diabetes Cost-effectiveness Study Group The cost-effectiveness of screening for Type 2 diabetes. JAMA 1998, 280:1757-1763.
109. Gong Q., Gregg E.W., Wang J., An Y., Zhang P., Yang W., et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: The China Da Qing diabetes prevention outcome study. Diabetologia 2011, 54:300-307.
110. Laatikainen T., Dunbar J.A., Chapman A., Kilkkinen A., Vartiainen E., Heistaro S., et al. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green triangle (GGT) diabetes prevention project. BMC Public Health 2007, 7:249. 10.1186/1471-2458-7-249.
111. Sukala W.R., Page R., Cheema B.S. Targeting the type 2 diabetes epidemic in Polynesia: historical perspective and rationale for exercise intervention trials. Ethn Dis 2012, 22:123-128.
112. Weng J., Li Y., Xu W., Shi L., Zhang Q., Zhu D., et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: A multicentre randomised parallel-group trial. Lancet 2008, 371:1753-1760.
113. Urakami T., Suzuki J., Mugishima H., Amemiya S., Sugihara S., Kawamura T., et al. Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan. Pediatr Endocrinol Rev 2012, 10(Suppl. 1):51-61.
114. Wei J., Sung F., Lin C., Lin R., Chiang C., Chuang L. National surveillance for type 2 diabetes mellitus in Taiwanese children. JAMA 2003, 290:1345-1350.
115. Norris S.L., Lau J., Smith S.J., Schmid C.H., Engelgau M.M. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002, 25:1159-1171.
116. Zhang X., Norris S.L., Gregg E.W., Cheng Y.J., Beckles G., Kahn H.S. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 2005, 161:652-660.
117. Campbell S.M., Reeves D., Kontopantelis E., Sibbald B., Roland M. Effects of pay for performance on the quality of primary care in England. N Engl J Med 2009, 361:368-378.
118. Farmer S.A., Black B., Bonow R.O. Tension between quality measurement, public quality reporting, and pay for performance. JAMA 2013, 309:349-350.
119. Institute of Medicine Crossing the quality chasm: a new health system for the 21st century. 2001: http://www.nap.edu/books/0309072808/html/.
120. Ellrodt G., Cook D.J., Lee J., Cho M., Hunt D., Weingarten S. Evidence-based disease management. JAMA 1997, 278:1687-1692.
121. IDF Clinical Guidelines Task Force Global guideline for type 2 diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006, 23:579-593.
122. Tricco A.C., Ivers N.M., Grimshaw J.M., Moher D., Turner L., Galipeau J., et al. Effectiveness of quality improvement strategies on the management of diabetes: A systematic review and meta-analysis. Lancet 2012, 379:2252-2261.
123. Chan J.C. What have we learnt from recent blood glucose lowering megatrials. J Diabetes Invest 2011, 10.1111/j.2040-1124.2010.00063.x.
124. Wu J.Y., Leung W.Y., Chang S., Lee B., Zee B., Tong P.C., et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: Randomised controlled trial. BMJ 2006, 333:522.
125. Ko G.T., So W.Y., Tong P.C., Le Coguiec F., Kerr D., Lyubomirsky G., et al. From design to implementation--the Joint Asia Diabetes Evaluation (JADE) program: A descriptive report of an electronic web-based diabetes management program. BMC medical informatics and decision making 2010, 10:26. 10.1186/1472-6947-10-26.
126. So W.Y., Raboca J., Sobrepena L., Yoon K.H., Deerochanawong C., Ho L.T., et al. Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program. Journal of diabetes 2011, 3:109-118.
127. World Health Organization Updated revised draft global action plan for the prevention and control of noncommunicable diseases 2013-2020 2013.
128. Pan X.R., Li G.W., Hu Y.H., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care 1997, 20:537-544.
129. WHO.WHO definition of health Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference 1948.
130. Western Pacific Declaration on Diabetes Steering Committee Plan of Action (2006-2010) for the Western Pacific Declaration on Diabetes: from evidence to action 2008, World Health Organization Western Pacific Regional Office, Manila, Philippines, available at www.wpdd.org.